qPCR as well as Western blotting (WB) results showed that MYLK2 expression was relatively high in PC-3 and LNCap cells compared to the normal prostate cancer cell line RWPE-1 (Figures 6A, B). This evidence concerns the gene MYLK2 and prostate carcinoma.